Koesten Hirschmann & Crabtree’s Vanguard FTSE Developed Markets ETF VEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$941K Sell
13,205
-46
-0.3% -$3.2K 0.39% 18
2026
Q1
$849K Hold
13,251
0.41% 18
2025
Q4
$828K Sell
13,251
-455
-3% -$27.9K 0.41% 17
2025
Q3
$821K Buy
13,706
+10
+0.1% +$583 0.39% 17
2025
Q2
$781K Buy
13,696
+7,407
+118% +$397K 0.4% 17
2025
Q1
$320K Buy
6,289
+8
+0.1% +$405 0.18% 27
2024
Q4
$300K Buy
6,281
+2,429
+63% +$122K 0.17% 28
2024
Q3
$203K Sell
3,852
-2,644
-41% -$134K 0.12% 33
2024
Q2
$326K Hold
6,496
0.21% 24
2024
Q1
$326K Sell
6,496
-143
-2% -$6.91K 0.21% 24
2023
Q4
$318K Buy
6,639
+3,132
+89% +$140K 0.22% 22
2023
Q3
$153K Sell
3,507
-119
-3% -$5.45K 0.12% 29
2023
Q2
$167K Sell
3,626
-119
-3% -$5.47K 0.13% 29
2023
Q1
$169K Sell
3,745
-78
-2% -$3.48K 0.13% 29
2022
Q4
$160K Buy
+3,823
New +$155K 0.13% 28

Other funds holding VEA

Koesten Hirschmann & Crabtree's VEA Position: Q2 2026 in Review

Koesten Hirschmann & Crabtree reduced its Vanguard FTSE Developed Markets ETF (VEA) stake by 0.35% in Q2 2026, selling an estimated $3.2K and leaving 13,205 shares worth $941K. The position accounts for 0.39% of the portfolio, ranked #18.

Koesten Hirschmann & Crabtree first reported a position in VEA in Q4 2022 and has held it in 15 quarters since. 1,116 funds tracked by Wall St. Rank hold VEA as of Q2 2026.

  • Koesten Hirschmann & Crabtree held 13,205 shares of Vanguard FTSE Developed Markets ETF worth $941K as of Q2 2026.
  • Koesten Hirschmann & Crabtree sold 46 Vanguard FTSE Developed Markets ETF shares in Q2 2026, an estimated $3.2K.
  • Vanguard FTSE Developed Markets ETF made up 0.39% of Koesten Hirschmann & Crabtree's portfolio in Q2 2026, its #18 holding.
  • Koesten Hirschmann & Crabtree first reported a position in Vanguard FTSE Developed Markets ETF in Q4 2022 and has held it in 15 quarters since.
  • 1,116 funds tracked by Wall St. Rank held Vanguard FTSE Developed Markets ETF as of Q2 2026.

Based on Koesten Hirschmann & Crabtree's 13F filing for Q2 2026, filed 20 Jul 2026.